Timothy Yap

Timothy Yap is a Senior Professor at The University of Texas MD Anderson Cancer Center, where he leads translational research in oncology and clinical pharmacology. His work focuses on developing novel therapeutic targets, including YAP/TEAD inhibitors, STING agonists, and USP1 inhibition, with recent breakthroughs published in *Nature Medicine* and *Nature Reviews Clinical Oncology*. He specializes in precision oncology, utilizing transcriptomic profiling to guide treatment in advanced solid tumors, and investigates replication stress and innate immune signaling in head and neck squamous cell carcinoma. His research bridges early-phase clinical trials and mechanistic drug development, earning recognition for advancing targeted therapies and overcoming resistance in breast cancer.